Skip to contentM
Myriad Genetics Inc
M
MYGNMyriad Genetics Inc Q3 2016 · 10-Q
Revenue$190.50M$190.50M+5.8% vs Q3 2015 Net Income$34.50M$34.50M+61.2% vs Q3 2015 EPS Diluted$0.47$0.47+62.1% vs Q3 2015 Operating Income$42,600,000+19.3% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Myriad Genetics Inc · CIK 899923 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$45,200,000+77.3% Margins · derivedOperating margin22.4%+2.5 pt vs Q3 2015
Net margin18.1%+6.2 pt vs Q3 2015
ended Mar 31, 2016 · filed May 4, 2016 · 34 d after period end